ADAR2 overexpression resulted in dramatically reduced PKM2 and ACLY expression at the protein level (Supplementary Fig. S2I) and led to a notable reduction in the aerobic glycolysis, lactate production, glucose utilization, lipogenesis, and proliferation of GBM cells (Fig. 2C–J). Here, PKM is linked to glioblastoma.